The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism

被引:52
|
作者
Cuevas-Ramos, Daniel [1 ]
Almeda-Valdes, Paloma [1 ]
Aguilar-Salinas, Carlos A. [1 ]
Cuevas-Ramos, Gabriel [2 ]
Cuevas-Sosa, Andres A. [3 ]
Gomez-Perez, Francisco J. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Vasco Quiroga 15,Secc XVI, Mexico City 14000, DF, Mexico
[2] Ecole Natl Veterinaire Toulouse, Toulouse, France
[3] Centro Invest Psicoanal & Psicoterapia, Mexico City, DF, Mexico
关键词
Fibroblast growth factor 21; Glucose; Energy balance; Insulin; Metabolic syndrome; Type 2 diabetes mellitus;
D O I
10.2174/157339909789804396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FGF21 is a novel member of the FGFs family, is mainly expressed in liver and it functions as a potent activator of glucose uptake on adipocytes. When over expressed in transgenic mice, it protects animals from diet-induced obesity and its administration to diabetic rodents and monkeys lowers blood glucose and triglyceride levels. Recently, increased levels of FGF21 have been identified as an independent risk factor related with metabolic syndrome. A review of the relevant roles of FGF21 in metabolism is presented here.
引用
收藏
页码:216 / 220
页数:5
相关论文
共 50 条
  • [41] EXPRESSION OF PLACENTAL FIBROBLAST GROWTH FACTOR 21 (FGF21) IS INCREASED IN PLACENTAL TISSUE FROM PREGNANCIES WITH PREECLAMPSIA
    Romero, Katherin Scholz
    Barrett, Helen
    Kubala, Marta
    McIntyre, David
    Callaway, Leonie
    Nitert, Marloes Dekker
    PLACENTA, 2014, 35 (09) : A84 - A84
  • [42] REGULATION OF HEPATIC FIBROBLAST GROWTH FACTOR 21(FGF21) EXPRESSION AND SECRETION BY THYROID HORMONE RECEPTOR β(TRβ)
    Xia, Xuefeng
    Zhang, Aijun
    Deng, Tuo
    Sieglaff, Douglas H.
    Estrada, Mayra
    Lin, Jean
    Li, Lifei
    Hsueh, Willa
    Baxter, John
    Webb, Paul
    HEPATOLOGY, 2010, 52 (04) : 590A - 590A
  • [43] EFFECTS OF INTRACEREBROVENTRICULAR FGF21 INFUSION ON THE ENERGY METABOLISM
    Yilmaz, U.
    Tekin, S.
    Demir, M.
    Cigremis, Y.
    Sandai, S.
    ACTA PHYSIOLOGICA, 2017, 221 : 138 - 138
  • [44] Combination of metformin plus orlistat prevents tumor progression: novel role of the metabolic hormone fibroblast growth factor 21 (FGF21)
    Sivaram, Shobika
    Baljinnyam, Erdene
    Iwatsubo, Kousaku
    Puricelli, Lydia I.
    De Lorenzo, Mariana S.
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Fibroblast Growth Factor Receptor-2 Involved in FGF-21-mediated Glucose Metabolism
    Ren Gui-Ping
    Li Lu
    Sun Guo-Peng
    Hou Yu-Ting
    Wang Wen-Fei
    Li De-Shan
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (02) : 165 - 174
  • [46] EFFECTS OF CENTRAL FIBROBLAST GROWTH FACTOR 21 IN ENERGY BALANCE
    Recinella, L.
    Leone, S.
    Ferrante, C.
    Chiavaroli, A.
    Di Nisio, C.
    Martinotti, S.
    Vacca, M.
    Brunetti, L.
    Orlando, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (03): : 603 - 613
  • [47] Fibroblast growth factor-21, energy balance and obesity
    Giralt, Marta
    Gavalda-Navarro, Aleix
    Villarroya, Francesc
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 418 : 66 - 73
  • [48] Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy
    Zhang, Zhensheng
    Xu, Li
    Qiu, Xun
    Yang, Xinyu
    Lian, Zhengxing
    Wei, Xuyong
    Lu, Di
    Xu, Xiao
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (06): : 485 - 495
  • [49] MECHANISMS OF FIBROBLAST GROWTH FACTOR 21 (FGF21) MEDIATED GROWTH HORMONE RESISTANCE IN HUMAN GROWTH PLATE IN CHRONIC CHILDHOOD CONDITIONS
    Mistry, Jayna N.
    Ruiz-Babot, Gerard
    Zaman, Farasat
    Savendahl, Lars
    Guasti, Leonardo
    Dunkel, Leo
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 4 - 4
  • [50] Raised circulating fibroblast growth factor 21 (FGF21) coupled with reduced adipose tissue BetaKlotho and FGF21 receptor 1 (FGFR1) expression in Type 2 diabetes may in part explain FGF21 resistance
    Piya, M. K.
    Harte, A. L.
    Kyrou, I.
    Chitari, M. V.
    Tripathi, G.
    Kumar, S.
    McTernan, P. G.
    DIABETIC MEDICINE, 2013, 30 : 3 - 3